 Home > Medical News > Medicines Company News > Bioved announces results of a Phase III randomized clinical trial of COVID

Bioved announces results of a Phase III randomized clinical trial of COVID

 Last Update: 2022-12-30
 Source: Internet
 Author: User

Tags

1 6 symbol

natural

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The results of an article published on November 25, 2022 in the highly respected peer-reviewed journal Phytotherapy Research showed a statistically significant reduction
in disease duration and severity of COVID-related symptoms.
In addition, from day 5, statistical importance was also found in relieving symptoms such as taste and smell
.
Most importantly, there was a statistically significant reduction in interleukin-6, a key biomarker that predictors immune disorders, acute respiratory distress, mortality, and long-term COVID
.
Another subgroup analysis showed that remdesivir for standard care was adjunctive.

Deepa Chitre, MD and CEO, said: "We are very encouraged
by the results of the study.
She further stated that Artovid-20® is one of
the most scientifically validated products in Ayurvedic science.
Bioved has a proprietary technology of natural plant extraction and a U.
S.
-patented method
.
The company's subsidiary conducted rapid testing and full-scale preclinical development
in Pune, India.
"We have several FDA-registered and audited laboratories
in India," said Dr.
Chitre.
The trial conducted extensive toxicity studies on Artovid-20® to prove its safety
.
Recent results from this double-blind, placebo-controlled, multicenter study show that the product has the potential to be used as an immunomodulator to help suppress other viral infections and for long-term COVID-19
applications.

Bioved is headquartered in San Jose, California, with subsidiaries
in Pune, India and Hanoi, Vietnam.
"We have a very robust discovery platform with safe and effective natural plant nutrition, dietary supplements and over-the-counter products
derived from Ayurvedic science.
Our products are sold
in several countries in the Asia-Pacific region and the United States.
Our aspiration is to make Artovid-20® tablets available to the general public, especially those developing countries
that have been and are still suffering from the challenges of the pandemic.
As a minority-owned women-owned business, Dr.
Chitre is proud
of Bioved's science and quality control in every product.

={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)];

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.